- Home
- » Tags
- » Troglitazone
Top View
- Induced Liver Injury
- Troglitazone Reduces Hyperglycaemia and Selectively Acute-Phase Serum Proteins in Patients with Type II Diabetes
- Conflict of Interest Disclosures
- The Effects of Long-Term Metformin Treatment on Adrenal and Ovarian Steroidogenesis in Women with Polycystic Ovary Syndrome
- A Model of Idiosyncratic, Drug-Induced Liver Injury
- Customised in Vitro Model to Detect Human Metabolism-Dependent
- Effect of Combination Treatment of S–Amlodipine with Peroxisome
- Analysis of Four Hepatotoxicants Using the Xcelligence Analytical System and Heparg Cells (030514) ¹Can Jin, ²David Steen, ²Valery Schevchenko
- Poster Abstracts
- Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
- Transcriptional, Functional, and Mechanistic Comparisons of Stem
- Regular Article the Quantitative Prediction of in Vivo Enzyme-Induction Caused by Drug Exposure from in Vitro Information on Human Hepatocytes
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Heparg Cells As an in Vitro Model for Evaluation of Cytochrome P450
- 1David M. Stresser, 1Reena Patel, 1Robert J. Clark, 1Thuy Ho, 1Sarah K. 1Trisdale, Ye Fang2, and 1J. George Zhang
- Customs Tariff - Schedule
- Effect of Fifteen CYP3A4 in Vitro Inducers on the Induction of P119 CYP2B6, CYP2C8, CYP2C9, CYP2C19 and CYP3A5 in Plated Human Hepatocytes: a Trend Analysis J
- The Multi-Facets of the Antitumor Effect of Thiazolidinediones
- Compounded Medications
- Pioglitazone and Rosiglitazone
- Thiazolidenediones Mediate Apoptosis in Prostate Cancer Cells in Part Through Inhibition of Bcl-Xl/Bcl-2 Functions Independently of PPAR;
- Interaction Between Amlodipine and Simvastatin in Patients with Hypercholesterolemia and Hypertension
- Glutathione S-Transferase M1 and T1
- Ovarian Suppression and Treatment of Hirsutism
- Repaglinide/Troglitazone Combination Therapy Improved Glycemic Control in Type 2 Diabetes
- Troglitazone Improves Psoriasis and Normalizes Models of Proliferative
- (12) United States Patent (10) Patent No.: US 8,765,725 B2 Cavanagh Et Al
- ESTROGEL® (17Β- Sooner If the Ovaries Have Been Removed by Surgery
- Troglitazone Stimulates Beta-Arrestin-Dependent Cardiomyocyte Contractility Via the Angiotensin II Type 1A Receptor
- Mechanistic Insights Into Side Effects of Troglitazone and Rosiglitazone Using a Novel Inverse Molecular Docking Protocol
- 2010 Nhamcs Micro-Data File Documentation Page 1
- LOESTRIN Label
- The Angiotensin II Type 1 Receptor Antagonist Telmisartan Inhibits Cell
- Supplementary Table 1: List of Drugs and Their Binding Energies to ACE and ACE2
- Rezulin® (Troglitazone) Tablets
- Multi-Ethnic Distribution of Clinically Relevant CYP2C Genotypes and Haplotypes
- Pharmaceutical Appendix to the Tariff Schedule 2
- Supplemental Table 1
- Drug-Induced Idiosyncratic Hepatotoxicity —Prevention Strategy Developed After the Troglitazone Case
- EASL Clinical Practice Guidelines: Drug-Induced Liver Injuryq
- Pharmacogenetic Analysis of Rosiglitazone-Induced Hepatosteatosis in New Mouse Models of Type 2 Diabetes Huei-Ju Pan,1 Peter Reifsnyder,1 Dennis E
- Estrogen Sulfotransferase (SULT1E1): Its Molecular Regulation, Polymorphisms, and Clinical Perspectives
- Comparison of Ethinyl-Estradiol Plus Cyproterone Acetate Versus Metformin Effects on Classic Metabolic Cardiovascular Risk Facto
- JPET #246751 Title